"Till Zimmer, PhD, studied applied biology in Rheinbach, Germany, at the University of Applied Sciences from 2010 to 2013, where he focused primarily on practical skills in the fields of cell biology and genetic engineering. His bachelor's thesis focused on the endocannabinoid system in neuron–microglia communication at the Institute of Molecular Psychiatry at the University of Bonn under the supervision of Dr. Andreas Zimmer.
In 2014, Dr. Till joined a master's degree program in neuroscience, also at the University of Bonn. For his thesis project, he investigated the cannabinoid type 2 receptor in inflammatory conditions at the Institute for Molecular Psychiatry under the supervision of Dr. Andreas Zimmer.
In January 2017, Dr. Till joined the group of Dr. Eleonora Aronica in the Department of Neuropathology of the Academic Medical Center in Amsterdam, focusing on inflammatory processes, oxidative stress, and iron in epilepsy. During his PhD training, Dr. Till was a fellow of the Marie Skłodowska-Curie Actions under the European Union's Horizon 2020 Program. In 2021, he was recruited as a postdoctoral associate at Weill Cornell Medicine in the Helen and Robert Appel Alzheimer's Disease Research Institute, where he works alongside Dr. Anna Orr and Dr. Adam Orr, focusing on astrocyte lipid metabolism and related processes in the context of dementia."